Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed COO
|
|
Avalon GloboCare Corp. (AVCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/13/2023 |
8-K
| Quarterly results |
| 08/21/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"NOW THEREFORE, in consideration of the foregoing and of the agreements and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Buyer hereby agree as follows: 1. Purchase and Sale of Note. a. Purchase of Note. On the Closing Date , the Company shall issue and sell to the Buyer, and the Buyer agrees to purchase from the Company, the Note, as further provided herein. As used in this Agreement, the term “business day” shall mean any day other than a Saturday, Sunday, or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order to remain closed. b. Form of Payment. On the Closing Date: the Buyer shall pay the purchase price of $475,...",
"W I T N E S S E T H:",
"SENIOR SECURED PROMISSORY NOTE",
"EXHIBIT A",
"EXHIBIT A" |
|
| 06/29/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/29/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/16/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/16/2023 |
8-K
| Investor presentation |
| 05/26/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"NOW THEREFORE, in consideration of the foregoing and of the agreements and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Buyer hereby agree as follows: 1. Purchase and Sale of Note. a. Purchase of Note. On the Closing Date , the Company shall issue and sell to the Buyer, and the Buyer agrees to purchase from the Company, the Note, as further provided herein. As used in this Agreement, the term “business day” shall mean any day other than a Saturday, Sunday, or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order to remain closed. b. Form of Payment. On the Closing Date: the Buyer shall pay the purchase price of $ 1,4...",
"W I T N E S S E T H:",
"SENIOR SECURED PROMISSORY NOTE",
"EXHIBIT A",
"EXHIBIT A",
"FORM OF BALLOON MORTGAGE NOTE",
"FORM OF SECOND MORTGAGE AND SECURITY AGREEMENT",
"FORM OF GUARANTY",
"FORM OF HAZARDOUS MATERIAL GUARANTY AND INDEMNIFICATION AGREEMENT" |
|
| 05/26/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS On February 9, 2023 , Avalon GloboCare Corp. entered into and closed an Amended and Restated Membership Interest Purchase Agreement , by and among Avalon Laboratory Services, Inc., a wholly-owned subsidiary of the Company , SCBC Holdings LLC , the Zoe Family Trust, Bryan Cox and Sarah Cox as individuals , and Laboratory Services MSO, LLC. The Amended MIPA amends and restates, in its entirety, that certain Membership Interest Purchase Agreement, dated November 7, 2022 . Pursuant to the terms and conditions set forth in the Amended MIPA, Buyer acquired from the Seller, forty percent of all the issued and outstanding equity interests of Laboratory Services MSO, LLC , free and clear of all liens . The consideration paid by Buyer to Seller f..." |
|
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
8-K/A
| Quarterly results |
| 03/22/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 03/09/2023 |
4
| Tauzin W J (Director) has filed a Form 4 on Avalon GloboCare Corp.|
Txns:
| Granted 4,000 options to buy
@ $5.2, valued at
$20.8k
Granted 8,000 options to buy
@ $4.3, valued at
$34.4k
Granted 8,000 options to buy
@ $5.3, valued at
$42.4k
Granted 4,000 options to buy
@ $8.2, valued at
$32.8k
Granted 8,000 options to buy
@ $10.3, valued at
$82.4k
Granted 8,000 options to buy
@ $10.2, valued at
$81.6k
Granted 4,000 options to buy
@ $11.2, valued at
$44.8k
|
|
| 03/09/2023 |
4
| Sanders Steven Andrew (Director) has filed a Form 4 on Avalon GloboCare Corp.|
Txns:
| Granted 8,000 options to buy
@ $5.2, valued at
$41.6k
Granted 8,000 options to buy
@ $8.2, valued at
$65.6k
Granted 8,000 options to buy
@ $11.2, valued at
$89.6k
|
|
| 03/08/2023 |
4
| Stilley William B. III (Director) has filed a Form 4 on Avalon GloboCare Corp.|
Txns:
| Granted 8,000 options to buy
@ $5.2, valued at
$41.6k
Granted 8,000 options to buy
@ $8.2, valued at
$65.6k
Granted 8,000 options to buy
@ $11.2, valued at
$89.6k
|
|
| 03/08/2023 |
4
| Troy Tevi (Director) has filed a Form 4 on Avalon GloboCare Corp.|
Txns:
| Granted 8,000 options to buy
@ $5.2, valued at
$41.6k
Granted 8,000 options to buy
@ $8.2, valued at
$65.6k
Granted 8,000 options to buy
@ $11.2, valued at
$89.6k
|
|
| 03/07/2023 |
3
| Felix Lourdes (Director) has filed a Form 3 on Avalon GloboCare Corp. |
| 02/13/2023 |
8-K
| Quarterly results |
| 01/23/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/11/2023 |
8-K
| Appointed a new director |
| 01/04/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 12/30/2022 |
8-K
| Quarterly results |
| 12/14/2022 |
8-K
| Quarterly results |
| 12/12/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/25/2022 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 11/21/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 11/08/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"MEMBERSHIP INTEREST PURCHASE AGREEMENT BY AND AMONG LaBORATORY SERVICES MSO, LLC , SCBC HOLDINGS LLC , THE ZOE FAMILY TRUST, BRYAN COX and SARAH COX , Avalon Laboratory Services, Inc. , and, solely for purposes of Sections 2.8 , 2.9 , 2.12 , 6.9 , 6.10 and 9.2 , AVALON GLOBOCARE CORP. , Dated November 7, 2022",
"Avalon GloboCare Corp. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE delaware GENERAL CORPORATION LAW The undersigned, Luisa Ingargiola, does hereby certify that: 1. The undersigned is the Chief Financial Officer of Avalon GloboCare Corp., a Delaware corporation . 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, $0.0001 par value per share. 3. On November 3, 2022, the following resolutions were duly adopted by the board of directors of the Corporation : WHEREAS, the Corporation’ s Amended and Restated Certificate of Incorporation authorizes the issuance of 10,000,000 shares of undesignated preferred stock, $0.0001 par value per share, issuable from time to time in one o...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of November 7, 2022, between Avalon GloboCare Corp., a Delaware corporation , and the purchaser identified on the signature page hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act of 1933, as amended , and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser ag...",
"Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million" |
|
|
|
|